BioCardia, Inc.

BCDA Nasdaq CIK: 0000925741

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 320 SOQUEL WAY, SUNNYVALE, CA, 94085
Mailing Address 320 SOQUEL WAY, SUNNYVALE, CA, 94085
Phone 650-226-0123
Fiscal Year End 1231
EIN 232753988

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events April 2, 2026 View on SEC
4 Insider stock transaction report March 26, 2026 View on SEC
10-K Annual financial report March 24, 2026 View on SEC
8-K Current report of material events March 24, 2026 View on SEC
8-K Current report of material events March 17, 2026 View on SEC
8-K Current report of material events March 3, 2026 View on SEC
8-K Current report of material events February 10, 2026 View on SEC
4 Insider stock transaction report February 4, 2026 View on SEC
8-K Current report of material events February 3, 2026 View on SEC
4 Insider stock transaction report January 21, 2026 View on SEC

Annual Reports

10-K March 24, 2026
  • Medicare coverage secured for CardiAMP heart failure trial routine costs
  • Promising clinical data showing 47% reduction in major heart events for high-stress patient subgroups
View Analysis

Insider Trading

BUY 1 insiders 7 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.